U.S. Wireless Telecom Stock News

NasdaqGS:MKSI
NasdaqGS:MKSISemiconductor

MKS Instruments SBTi Approval Adds ESG Dimension To Valuation Debate

MKS Instruments (NasdaqGS:MKSI) has received official validation of its near term greenhouse gas emissions reduction targets from the Science Based Targets initiative (SBTi). The validation confirms that MKS's climate goals are aligned with internationally recognized criteria for science based climate action. This development strengthens the company's environmental, social and governance (ESG) profile at a time when customers and investors are increasingly focused on sustainability. MKS...
NYSE:NWN
NYSE:NWNGas Utilities

Should Record 2025 EPS and Fastest Customer Growth in Decades Require Action From Northwest Natural (NWN) Investors?

Earlier in March 2026, Northwest Natural Holding was highlighted among the 11 best utility dividend stocks and reported record 2025 adjusted EPS of US$2.93 alongside its strongest organic customer growth in nearly two decades. This combination of robust earnings and accelerating customer additions suggests the company’s core utility and expansion initiatives are gaining meaningful operational traction. We’ll now examine how this record adjusted EPS performance shapes Northwest Natural...
NYSE:LOAR
NYSE:LOARAerospace & Defense

A Look At Loar Holdings (LOAR) Valuation After Insider Buying And Earnings Beat Near 52 Week Low

Loar Holdings (LOAR) is back on investors' radar after President and CEO Charles Dirkson bought approximately US$2.9 million of stock while shares traded near a 52 week low and recent quarterly earnings topped forecasts. See our latest analysis for Loar Holdings. The share price has been under pressure for most of the year, with a year-to-date share price return of a 7.92% decline and a 1-year total shareholder return of a 3.59% decline, even after a 2.60% gain in the last session and...
NYSE:ESNT
NYSE:ESNTDiversified Financial

Will Essent’s (ESNT) Flat Revenue and EPS Miss Reshape Its Profitability Narrative and Assumptions?

Essent Group recently reported its latest quarter, with revenues of US$312.4 million flat year on year and in line with expectations, but earnings per share fell short of analyst estimates, an update that now sits in the rear-view mirror as of 16 March 2026. Despite management highlighting resilient operations and a durable business model supporting access to homeownership through private mortgage insurance and title services, the profit shortfall has raised questions about the company’s...
NYSE:OBK
NYSE:OBKBanks

A Look At Origin Bancorp (OBK) Valuation After Recent Share Price Pullback

Origin Bancorp stock after recent performance shifts Origin Bancorp (OBK) has drawn attention after a recent share price move, with the stock closing at $40.61 and showing mixed returns over the past week, month, and past three months. See our latest analysis for Origin Bancorp. Taking a step back, the recent share price pullback sits alongside a 30 day share price return decline of 7.16%, while the 1 year total shareholder return of 15.15% and 3 year total shareholder return of 27.42% point...
NYSE:VAC
NYSE:VACHospitality

Assessing Marriott Vacations Worldwide (VAC) Valuation As Weak Demand And High Leverage Pressure Sentiment

Why recent weak demand and higher leverage matter for Marriott Vacations Worldwide (VAC) Recent commentary around Marriott Vacations Worldwide (VAC) has focused on soft tour volumes, shrinking returns on capital, and a high net-debt-to-EBITDA ratio, all occurring against a backdrop of pressure on travel stocks from geopolitical tensions and higher oil prices. See our latest analysis for Marriott Vacations Worldwide. The recent leadership changes, including the appointment of a new Executive...
NYSE:GPK
NYSE:GPKPackaging

Is It Time To Reconsider Graphic Packaging Holding (GPK) After Recent Share Price Strength?

To help you decide whether Graphic Packaging Holding might offer value at today’s price, this article focuses squarely on what the current share price implies about the company. Recently, the stock has been weak, with returns of 9.7% over 7 days, 21.7% over 30 days, 35.8% year to date, and 61.8% over the last year, which may indicate that expectations and risk perceptions have shifted. These moves come as the company continues to attract attention in packaging, where investors often weigh...
NasdaqGS:CACC
NasdaqGS:CACCConsumer Finance

Assessing Credit Acceptance (CACC) Valuation After Recent Share Price Pullback

Why Credit Acceptance Is on Investors’ Radar Without a single headline event driving attention, Credit Acceptance (CACC) is drawing interest as investors weigh its recent share performance against its current size, profitability profile, and niche in US auto financing. See our latest analysis for Credit Acceptance. The share price has stepped back to $447.79 after a 9.35% 1 day decline and a 10.72% 7 day share price return. The 1 year total shareholder return of an 8.02% decline contrasts...
NasdaqGS:EFSC
NasdaqGS:EFSCBanks

Is Enterprise Financial Services (EFSC) Offering Value After Recent Share Price Weakness?

Wondering if Enterprise Financial Services at around US$53.33 is offering good value or just fair value right now? This article breaks down what the current price may be implying. The stock has returned a loss of 2.3% over the past week and 12.3% over the past month, while the 3 year and 5 year returns sit at 22.2% and 20.1%. Recent coverage has focused on how regional banks are being assessed by investors, with attention on balance sheet strength, funding costs, and overall risk appetite...
NasdaqGS:FBNC
NasdaqGS:FBNCBanks

First Bancorp CEO Retirement Puts Focus On Leadership Continuity And Dividends

First Bancorp (NasdaqGS:FBNC) announced the retirement of Michael G. Mayer from his roles as President and CEO of First Bank. Mayer is stepping back from day to day management but will continue to serve on the company’s Board of Directors. The change marks a leadership transition at the top of First Bank’s operating structure. First Bancorp, the holding company for First Bank, operates as a regional banking platform, offering lending, deposit, and related financial services. Leadership...
NYSE:AMG
NYSE:AMGCapital Markets

A Look At Affiliated Managers Group’s Valuation After Recent Mixed Share Performance

Recent share performance and current business snapshot Affiliated Managers Group (AMG) has drawn attention after recent share moves, with the stock showing a 0.6% gain over the past day, alongside declines over the week and month. The company, an investment management firm with a market value of about US$7.3b, reports annual revenue of US$2,074.4m and net income of US$716.6m from its asset management operations. See our latest analysis for Affiliated Managers Group. Recent trading paints a...
BATS:CBOE
BATS:CBOECapital Markets

How Investors Are Reacting To Cboe Global Markets (CBOE) Extending VIX Tools Into Bitcoin And Prediction Markets

Cboe Global Markets, Inc. has announced plans to launch the Cboe IBIT Volatility Index and a new prediction markets framework, extending its VIX methodology into bitcoin and introducing three-outcome, fixed-return contracts initially tied to Mini S&P 500 Index prediction markets. By pairing a bitcoin volatility gauge with an options-style prediction market that allows partial payouts, Cboe is seeking to broaden access to outcome-based trading while aligning it with established exchange...
NasdaqGM:TRVI
NasdaqGM:TRVIPharmaceuticals

Assessing Trevi Therapeutics (TRVI) Valuation After FDA Alignment On Phase 3 IPF Chronic Cough Program

Trevi Therapeutics (TRVI) has secured FDA alignment on its clinical plan for nalbuphine ER in IPF related chronic cough, clearing the way for two randomized, double blind, placebo controlled Phase 3 trials starting later this year. See our latest analysis for Trevi Therapeutics. That FDA alignment comes after a recent pullback, with a 7 day share price return showing a decline of 17.22% and a 90 day share price return showing a decline of 12.69%. However, the 1 year total shareholder return...
NYSE:NGL
NYSE:NGLOil and Gas

Assessing NGL Energy Partners (NGL) Valuation After Its US$950m Refinancing And Capital Structure Reset

NGL Energy Partners (NGL) has drawn fresh investor attention after closing a seven year US$950 million senior secured term loan and amending its asset based revolving credit facility to reshape its capital structure. See our latest analysis for NGL Energy Partners. These financing moves come after a strong run for investors, with the 1 year total shareholder return at about 140%. At the same time, the recent 1 month share price return of a 6.67% decline suggests some cooling in short term...
NasdaqGS:AEVA
NasdaqGS:AEVAElectronic

Is Aeva Technologies' (AEVA) Sales Streak Quietly Rewriting Its Risk‑Reward Profile?

Aeva Technologies recently presented at the Morgan Stanley Technology, Media & Telecom Conference and the 2nd Annual CG Virtual Sustainability Summit, and has since marked its fifth anniversary as a public company by ringing the Nasdaq Closing Bell. Together with expanding its next-generation perception platform into factory automation, smart infrastructure and defense, Aeva has also delivered five consecutive quarters of rising net sales, indicating building operational momentum despite...
NasdaqGS:MGEE
NasdaqGS:MGEEElectric Utilities

Assessing MGE Energy (MGEE) Valuation After Insider Buying And Earnings Beat

Insider buying and earnings beat put MGE Energy (MGEE) back on investor radar Recent insider buying by director James G. Berbee, a fourth quarter revenue beat, continued dividend growth, and a fresh sector update from Morgan Stanley have drawn new attention to MGE Energy (MGEE). See our latest analysis for MGE Energy. Even with insider buying and upbeat earnings, the recent 7 day share price return of 6.36% and 30 day share price return of 9.79% show pressure on the stock. The 1 year total...
NYSE:CE
NYSE:CEChemicals

What Does Celanese’s (CE) Board Change Reveal About Its Margin Power Amid Supply Strains?

Celanese Corporation recently reported that Timothy Go resigned from its Board of Directors on February 27, 2026, with the company clarifying that his departure was not due to any disagreement over operations, policies, or practices. At the same time, analysts have highlighted Celanese’s ability to push through price increases and potentially widen margins amid tighter global supply chains and geopolitical disruptions, reshaping how investors view its earnings power under stressed market...
NYSE:VSH
NYSE:VSHElectronic

A Look At Vishay Intertechnology (VSH) Valuation After Recent Share Price Swings

Why Vishay Intertechnology (VSH) Is On Investors’ Radar Today Vishay Intertechnology (VSH) is drawing attention after recent share price moves that include a gain over the past 3 months alongside a month pullback, putting its current US$17.23 price in focus. See our latest analysis for Vishay Intertechnology. That recent 3 month share price return of 13.73% sits alongside a 30 day share price pullback of 8.74% and a more modest 1 year total shareholder return of 4.82%. Together, these figures...
NYSE:AVA
NYSE:AVAIntegrated Utilities

Is It Time To Reconsider Avista (AVA) After Recent Share Price Weakness?

If you are wondering whether Avista's current share price lines up with its underlying value, this article will walk through what the key numbers are really saying. Over the past week Avista has a 0.5% return, compared with a 7.5% decline over the last 30 days and returns of 3.0% year to date and 4.9% over 1 year, with a 3 year return of 11.7% and 5 year return of 8.8% that can help frame how the current US$39.87 share price fits into its recent history. Recent price moves have come against...
NasdaqGS:CGON
NasdaqGS:CGONBiotechs

How Investors May Respond To CG Oncology (CGON) Expanding ATM Offering To Advance Cretostimogene BLA Efforts

In recent days, CG Oncology drew attention as multiple research firms updated their views on the company, while it expanded its at-the-market stock offering to up to US$550 million to support progress toward a Biologics License Application for its bladder cancer therapy candidate, cretostimogene. Analysts pointed to recent clinical and market validation in intermediate-risk non-muscle invasive bladder cancer and CG Oncology’s advancing PIVOT-006 trial as important factors shaping how...
NYSE:DAO
NYSE:DAOConsumer Services

Assessing Youdao (DAO) Valuation After The Launch Of Its Open-Source Lobster AI Agent

Why Youdao’s New AI Agent Matters for Investors Youdao (NYSE:DAO) has launched Youdao Lobster, described as China’s first fully open-source AI Agent, featuring a 5,000 plus skill store and integration with popular office messaging platforms. This launch highlights Youdao’s push into AI based tools and gives investors a fresh development to assess alongside the company’s existing learning services, smart devices, and online marketing businesses in China. See our latest analysis for...
NYSE:ATHM
NYSE:ATHMInteractive Media and Services

How Investors May Respond To Autohome (ATHM) Buybacks Amid Softer 2025 Earnings

Autohome Inc. recently reported fourth-quarter and full-year 2025 results showing lower revenue and net income year over year, while also confirming that it completed a prior buyback of 7,116,939 shares for US$184.50 million. On the same day, the Board authorized a new share repurchase program of up to US$200 million funded from existing cash, highlighting management’s continued focus on capital returns even as earnings softened. Now we’ll explore how the new US$200 million repurchase plan,...
NYSE:VIA
NYSE:VIASoftware

Via Transportation (VIA) Valuation Check After Recent Share Price Weakness

Recent price performance and business snapshot Via Transportation (VIA) has drawn attention after its share price declined about 7% over the past week and roughly 43% over the past 3 months, putting recent trading under closer investor review. The New York based transit software company reports annual revenue of US$434.3 million and a net loss of US$96.4 million. Its services span planning tools, operations software, and tech enabled transit solutions for public and private clients. See our...
NasdaqGS:CERT
NasdaqGS:CERTHealthcare Services

Assessing Certara (CERT) Valuation After FDA PBPK Milestone And New Biosimulation Software Launches

Certara (CERT) is back on investors’ radar after closing 2025 with revenue of US$418.8m, a small net loss, and fresh FDA validation of its biosimulation platform through PBPK modeling used in the asciminib NDA. See our latest analysis for Certara. Despite FDA validation for its PBPK work and new software launches, Certara’s share price has been under pressure, with a 90 day share price return of 23.91% and a 1 year total shareholder return of 39.10%. This may indicate fading momentum after...